ArticleFuture science OA2019

Molecular remission using low-dose immunotherapy for relapsed refractory Philadelphia chromosome-positive precursor B-cell acute lymphoblastic leukemia post-allogeneic stem cell transplant.

Dipnarine Maharaj et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.